BioMatt shares overall responsibilities for all management and investment activities of the firm. Matt has primary responsibility for Arlington’s healthcare investments and shares responsibility for the firm’s aerospace and defense investments. Matt has closed leveraged buyouts, recapitalizations and growth equity investments representing over $2.0 billion in value during his 18 year career in private equity. Matt� ....
Access "Matthew L. Altman" Work Experience (Current/Past), Board Seats, Joined Date, Contact Details - Emailid/Phone and Investments (If any)
in one connected platform (AcquityData).
We use essential cookies to run this site (like keeping you signed in), and — only with your consent — analytics cookies to understand how the site is used. See our
Privacy Policy for details on what we collect and why.